News Focus
News Focus
icon url

guzbug

01/12/06 9:13 AM

#449687 RE: madrose1 #449682

Mar, in looking over the two Cramer 'pumps', even though he gave MYOG second billing, it look like the better stock, for sure. Obviously, though, everyone will go for ZGEN because it's 'cheaper?'for the 'play'. It's drug is only in Stage 1b trials....makes me think even $20 is lofty. but wthdik?
icon url

zentman

01/12/06 9:24 AM

#449697 RE: madrose1 #449682

I rarely make a trade in the first 20 minutes of the market anyway. :)